TH1834 is a selective inhibitor of the Tip60 (KAT5) histoneacetyltransferase (HAT). It effectively induces apoptosis and promotes DNA damage in breast cancer cells. Notably, TH1834 does not influence the activity of the MOF histoneacetyltransferase, which is structurally related. Overall, TH1834 exhibits potent anticancer activity.